Tratamento e controle das reações hansênicas

Authors

  • Somei Ura Pesquisador científico V, Diretor da Divisão de Pesquisa e Ensino do ILSL. Divisão de Pesquisa e Ensino, ILSL.

DOI:

https://doi.org/10.47878/hi.2007.v32.35196

Abstract

.

Downloads

Download data is not yet available.

References

1 Opromolla DVA. Manifestações clínicas e reações. In: Noções de Hansenologia. 2ª. Ed. Bauru: Centro de Estudos “Dr. Reinaldo
Quagliatto”. Instituto Lauro de Souza Cima; 2000. p.51-58.
2 Saunderson P, Gebre S, Byass P. ENL reactions in the multibacilares cases of the AMFES cohort in the central Ethiopia: incidence and risk factors. Lepr rev 2000; 71: 318-324.
3 Saunderson P, Gebre S, Byass P. Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors. Lepr rev 2000; 71: 309-317
4 Kumar N, Droga S, Kaur I. Epidemiological characteristics of leprosy reactions: 15 years experience from North India. Int j lepr OtherMycobact Dis. 2004; 72(2):125-133.
5 Opromolla DVA. Some considerations on the origin of type 1 reactions in leprosy. Int j lepr Other Mycobact Dis. 2005; 73(1):33-34.
6 Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN. Clinical course of erythrma nodosum leprosum:
an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006 May; 74(5):868-79.

Published

2007-06-30

How to Cite

1.
Ura S. Tratamento e controle das reações hansênicas. Hansen. Int. [Internet]. 2007 Jun. 30 [cited 2024 May 15];32(1):67-70. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35196

Issue

Section

Educação continuada

Most read articles by the same author(s)

1 2 3 > >>